All News

At the American Heart Association's 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, explained how pharmacists can use a behaviorally tailored method of patient interviewing to assess patients' adherence barriers.

Exposure to ammonia found to amplify breast cancer cell proliferation.

The same genes may influence asthma, hay fever, and eczema risk.

Mortality risk may be significantly lowered among older women who participate in moderate to vigorous physical activity.

Significant gains have been made against viral hepatitis.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

FDA cites 36 reported deaths linked to use of kratom-containing products, including kratom being laced with opioids such as hydrocodone.

Officials with the FDA have approved benralizumab (Fasenra, AstraZeneca) for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older.

Officials with the FDA have issued a public health advisory on kratom, warning consumers about the potential risks associated with its use.

There is a growing need to develop standards for measuring outcomes among patients treated with specialty drugs.

Empagliflozin (Jardiance) reduced the risk of cardiovascular mortality by 43% in patients with type 2 diabetes and peripheral artery disease.

Identification of the last unknown protein in HIV could lead to a cure for the virus.

In this clip, Dr. Whelton discusses the guideline's emphasis on a team-based approach to assessing and treating hypertension in patients.

Semaglutide treatment sparked an average weight loss of 11 pounds over 12 weeks.

Proton beam therapy reduces toxicity among pediatric patients with head and neck cancer.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Aripiprazole tablets with sensor (Abilify MyCite) is approved to treat schizophrenia, manic and mixed episodes for patients with bipolar I disorder, and as an add-on for depression treatment.

Aripiprazole tablets with sensor (Abilify MyCite) transmits information to an app when ingested.

The guidelines, developed by the American Heart Association and the American College of Cardiology, lower the starting point for high blood pressure.

Nine other countries are on track to eliminate the hepatitis C virus by 2030.

Children and young adults with diabetes may have a 7-fold increased risk of sudden cardiac death than those without diabetes.

Cariprazine is a once-daily atypical antipsychotic for patients with bipolar I disorder and schizophrenia.

Rising health care expenditures within the United States has been a major focus of policy makers, business owners, and individuals for years.

Direct-acting oral anticoagulants, alternatives to warfarin, may be less dangerous, but pharmacists still must help keep patients safe.

When pharmacists promote behavioral changes, it encourages positive patterns that last a lifetime.

Having the necessary items will alleviate stress and help attendees have a successful conference.

The sensor that is used along with aripiprazole was first cleared for use by the FDA in 2012; however, the approval of the pill and the sensor together represents a first for the FDA.

President Trump has nominated Alex M. Azar II to be the next secretary of the United States Department of Health and Human Services.